تحذيرات السلامة

#	العنوان	نوع الخبر	التاريخ
90	The SFDA Advises to Avoid Using NSAIDs in Pregnancy at 20 Weeks or Later	Warning	2021-02-09
89	Safety Signal of Dolutegravir and the Risk of Hyperglycemia	Signal	2021-02-21
88	Safety Signal of Clopidogrel and the Risk of Hypertension	Signal	2021-02-21
87	Safety Signal of Agomelatine and the Risk of Hypertension	Signal	2021-02-17
86	Safety Signal of Indapamide and the Risk of Rhabdomyolysis	Signal	2021-01-21
85	Safety Signal of Theophylline and the Risk of Encephalopathy	Signal	2021-01-13
84	Safety Signal of Amitriptyline and the Risk of Drug Reaction with Eosinophilia and Systemic Symptoms	Signal	2021-01-03
83	Safety Signal of Nivolumab and the Risk of Hypoparathyroidism	Signal	2021-01-03
82	Potential Risk of Tumor Lysis Syndrome Associated with the Use Pazopanib	Precautions	2020-11-09
81	Baricitinib (Olumiant®) and increased risk of diverticulitis: Recommendations for Healthcare Professionals from the SFDA	Precautions	2020-09-02